François Houÿez

How Patients Can Contribute to the Assessments of Health Technologies

François Houÿez, Julien Delaye

In the process of determining whether a health technology should be covered by healthcare systems, patients and their representatives were initially excluded from both evaluations and decision-making. In Europe, direct dialogue between patient organisations and regulatory authorities-particularly in the pharmaceutical sector-began in …

fr (code pays fourni par la source)

How to Teach an Old Medicine New Tricks: The Importance of Repurposing Medicines for Patients

François Houÿez

Eurordis, the European Organisation for Rare Diseases, representing more than 1075 patient groups and around 2000 distinct rare diseases, exists since 1997. The first purpose of creating Eurordis by that time was to support the adoption of the EU Regulation on Orphan …

fr (code pays fourni par la source)

Incorporating cost considerations into shared decision-making: lessons from Bulgaria

Guenka Petrova, Maria Kamusheva, Konstantin Tachkov, Maria Dimitrova et autres

This study aims to explore the need for and acceptability of incorporating treatment costs into shared decision-making (SDM) among patients and healthcare providers (HCPs) in Bulgaria. This study is a qualitative, non-interventional evaluation of patients’ and healthcare professionals’ needs, acceptability, and perceived …

bg, hu, be (code pays fourni par la source)

Empowering Patients in Health Technology Assessment: The European Capacity Building for Patients (EUCAPA) Initiative

Milena Muehler, Silke Siebert, Petra Schnell‐Inderst, Sonja Rossmann et autres

Background Although the European Union's new Health Technology Assessment Regulation (HTAR) underlines the growing importance of patient perspectives in HTA, patients often face barriers to effective participation due to limited access to engagement opportunities. The objective of this project was to develop, …

at, fr, lu, us (code pays fourni par la source)

PCR301 The EUCAPA Project: A Concept for Patient Engagement and Capacity Building for the New Health Technology Assessment Regulation

Milena Muehler, Sabina Siebert, Petra Schnell‐Inderst, Susan Rossmann et autres

at, fr, be, lu, hr (code pays fourni par la source)

PP60 Enhancing Patient Empowerment: European Capacity Building Initiative And Curriculum Development In Health Technology Assessment Training

Milena Muehler, Silke Siebert, Petra Schnell‐Inderst, Sibylle Puntscher et autres

Introduction The new Regulation (EU) 2021/2282 on health technology assessment (HTAR) highlights the increasing importance of patient perspectives, emphasizing their crucial role in HTA. The European Capacity Building for Patients (EUCAPA) project aims to empower patients for active involvement in HTA. EUCAPA …

An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators

Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys et autres

OBJECTIVES: Stakeholder involvement has long been considered a success factor for a joint European health technology assessment (HTA) process, and its relevance is now anchored in the EU HTA Regulation's (EU HTAR) legislative wording. Therefore, we aimed to explore the roles, challenges, …

be, gb, fr, nl, no, it, ch, es, de (code pays fourni par la source)

Implementing a sandbox approach in health technology assessment: benefits and recommendations

Jamie Elvidge, Nick Crabb, Diana Delnoij, Saskia Knies et autres

OBJECTIVES: The sandbox approach, developed in the financial technologies sector, creates an environment to collaboratively develop and test innovative new products, methods and regulatory approaches, separated from business as usual. It has been used in health care to encourage innovation in response …

gb, nl, se, fr, fi, Égypte (code pays fourni par la source)

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

Ivett Jakab, Maria Dimitrova, François Houÿez, Tamás Bereczky et autres

Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are …

hu, bg, fr, be, ua, si, es, sk, pl, ro, gb, nl (code pays fourni par la source)

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire

Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck et autres

Involvement of all relevant stakeholders will be of utmost importance for the success of the developing EU HTA harmonization process. A multi-step procedure was applied to develop a survey across stakeholders/collaborators within the EU HTA framework to assess their current level of …

be, de, ch, gb, fr, nl, no, it, es (code pays fourni par la source)

Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

Priya Bahri, Geoffrey Bowring, Brian Edwards, Christopher G. Anton et autres

published

nl, ch, se, gb, co, it, us, de, in, ph, fr, th, Tunisie, mt (code pays fourni par la source)

Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries

Maria Dimitrova, Ivett Jakab, Zornitsa Mitkova, Maria Kamusheva et autres

Patients' perspectives are important to identify preferences, estimate values and appreciate unmet medical needs in the process of research and development and subsequent assessment of new health technologies. Patient and public involvement in health technology assessment (HTA) is essential in understanding and …

bg, hu, Égypte, gb, nl, fr (code pays fourni par la source)